Skip to main content

Kock Pouch

The cutaneous urinary Kock pouch is a reconfigured ileal reservoir with two intussuscepted nipple valves: an afferent valve intended to prevent reflux toward the ureters and an efferent valve providing resistance at the catheterizable outlet. The orthotopic Kock neobladder retains the afferent valve but connects to the urethra; continence then depends on the urethral outlet rather than a cutaneous nipple.[1][2][3]

This reconstruction contributed substantially to continent urinary diversion. Its historical experience also demonstrates the long-term burden of valve dysfunction, exposed foreign material, stones and repeat surgery. Historical success does not establish that it is the best reservoir for a new patient.

Selection and Operative Framework​

Continent reconstruction requires suitable bowel, adequate renal and hepatic function, and the ability to maintain intermittent catheterization and follow-up. An orthotopic reservoir also requires an appropriate retained urethra and negative urethral margin in cancer surgery. AUA discusses eGFR below 45 mL/min/1.73 m² as an example of inadequate renal function for continent diversion; assess the individual rather than use an isolated creatinine cutoff.[4]

ComponentCutaneous Kock pouchOrthotopic Kock neobladder
ReservoirDetubularized ileum reconfigured for compliant storageReconfigured ileal reservoir
Ureteral drainageUreters enter an afferent ileal segment proximal to its nipple valveAfferent ileal segment with antireflux nipple
OutletEfferent intussuscepted valve and abdominal stomaReservoir-to-urethra anastomosis; no cutaneous efferent valve
EmptyingIntermittent catheterizationPelvic-floor relaxation with abdominal pressure; catheterization if required for safe emptying

The operative sequence comprises vascular assessment and bowel isolation, restoration of intestinal continuity, reservoir reconfiguration, valve construction, ureteral implantation, outlet creation and secure drainage. Preserve perfusion during any mesenteric window or intussusception and avoid tension, kinking or outlet obstruction. The early Skinner modification described mesenteric stripping and fixation to stabilize the valves; it should not be reduced to a universal strip-length or stapling instruction without the operative atlas.[1][5][3]

Historical nonabsorbable collars caused erosion and obstruction. Arai's 42-patient series identified 10 late afferent complications, including collar erosion, stenosis and obstruction by mucus or a fungus ball; the construction and its modifications must be specified when comparing outcomes.[6]

Detubularization reduces coordinated contractions but does not guarantee low pressure at every filling volume. Neither a reported maximum capacity of 1,400 mL nor a fixed catheterization interval is a treatment target. In the early 51-patient USC series, patients catheterized every 4–6 hours by day and once at night; current intervals should follow measured volumes, continence, pressure and emptying.[1]

Historical Outcomes: Preserve the Denominators​

Cutaneous reservoirs​

ReportPopulation and follow-upUseful result and limitation
Skinner 1987[7]250 patients; procedures 1982–198577 patients underwent 85 revisions for late complications; this is not a randomized comparison
Skinner 1988[5]531 overall; late cutaneous outcomes analyzed in 489Late complications fell to 22% after a 1985 technical modification; the rate is not 22% for every patient across all construction eras
Chen 1990[8]53 patients; 6–39 months45 had good continence; 4 had valve prolapse and 4 poor continence requiring more frequent catheterization
Henriet 1991[9]135 mixed reconstructions, including 72 cutaneous94.2% cutaneous continence; reported late complications differed by construction method
Arai 1993[10]76 Kock/39 Indiana operated; 68/37 followed at least 12 months, mean 53/34 monthsRevisions 15/68 versus 4/37; stones 18/68 versus 2/37. Longer Kock follow-up and historical collars complicate comparison
Okada 1996[11]102 Kock/61 Indiana operated; 95/59 followed beyond 3 months, mean 83/50 monthsKock open repair 36/95 and stones 42/95; “approximately 90% success” was not a 90% complete-continence rate

These reports overlap in centers and operative eras; their patients should not be pooled as independent observations. The comparison with Indiana illustrates device and technique effects as well as reservoir choice.

Orthotopic reservoirs​

ReportPopulationReported function
Ghoneim 1987[3]16 men; 3–9 monthsAll continent by day; 4 had nocturnal enuresis
Kock 1989[12]43 men; 34 functionally evaluable, mean 13 months30/34 continent day and night; 18/43 had reflux after valve eversion/sliding, managed with revision
Ghoneim 1992[13]185 operated; 117 fully evaluable beyond 1 year108/117 completely continent by day and 85/117 dry at night
Elmajian 1996[2]295 men87% daytime and 86% nighttime good or satisfactory continence; 5% regular catheterization. These are not strict pad-free rates
Steven 2000[14]166 men; serial follow-upHigh reported continence coexisted with nighttime protection and increasing catheterization requirements

In Steven's cohort, reported nighttime continence rose from 75% at one year to 94% at five years, but only 39.8% used no nighttime protection at one year and 45.9% at three years. Intermittent catheterization for residuals above 100 mL rose from 16% at six months to 44% at five years. The reported five-year risks were 34% for stones and 33% for B12 deficiency. Do not present the continence percentages as pad-free results or assume every original patient was assessed at five years.[14]

Urodynamics and Emptying​

In Chen's 20-patient cutaneous study, five had pressure spikes. Their mean maximal pouch pressure was 41 cm H₂O, compared with 11.6 cm H₂O in those without spikes. Nipple length and closure pressure correlated with capacity and catheterization frequency; these small-study findings are not a validated standalone diagnostic rule for valve failure.[15]

Gotoh's 18-man orthotopic study found a mean storage pressure of 33.2 cm H₂O and voiding pressure of 77.3 cm H₂O; eight had voiding pressures of 80–150 cm H₂O. One patient with reflux during high-pressure emptying started catheterization. A reservoir that stores adequately may still empty at excessive pressure: evaluate obstruction, residual volume and upper-tract changes rather than encourage progressively stronger straining.[16]

Valve Dysfunction and Stones​

Afferent obstruction​

The 802-patient USC report identified 79 patients with 84 afferent-valve complications: 42 stone events on staples, 35 stenoses and 7 prolapses. These are event counts, not separate mutually exclusive patient groups.[17]

A normal pouch contrast study does not exclude upstream obstruction. In Stein's 13-patient stenosis series, functional kidneys were hydronephrotic despite uniformly normal pouch radiographs. Seven patients needed a single dilation; six needed repeat dilation and four of those proceeded to open revision.[18]

Late problems can occur decades after construction. Locke's seven-case series had a median 17 years from diversion to valve intervention. All underwent upper-tract imaging and nephrostomy drainage; six ultimately had surgical repair and one had successful antegrade dilation. This is a small salvage series, not a universal requirement for immediate open repair.[19]

Outlet problems​

Incontinence, difficult catheterization, valve prolapse, fistula and false passage require assessment of the actual outlet and reservoir. Repeated traumatic catheter attempts can worsen access. Arai's long-term group had nine efferent malfunctions among 68 Kock patients, five requiring revision.[10]

Carr's sequential single-surgeon comparison found revisions in 16/30 Kock versus 4/30 right-colon patients. Median follow-up was 50 versus 16 months, and age and disease indications differed. This supports counseling about revision burden; it does not quantify an unbiased comparative treatment effect.[20]

Stones​

Ginsberg reported stones in 64/383 cutaneous reservoirs, often associated with exposed staples or eroded Marlex; 13 patients had recurrence. Terai's later comparison found stones in 31/72 Kock versus 7/54 Indiana pouches, with five-year stone-free estimates of 66% versus 84%. Construction era, infection, metabolic factors, irrigation and follow-up all affect interpretation.[21][22]

Plan stone access to protect the continence mechanism. EAU notes that endoscopy through a continent channel can damage it; percutaneous or open access is often preferred. Regular saline irrigation is a weak recommendation for reconstructed reservoirs in patients without a history of autonomic dysreflexia; individualize the regimen and teach it safely.[23]

Metabolic Surveillance​

Vitamin B12 malabsorption and low serum B12 are different outcomes. In Pannek's study, Schilling-test absorption was reduced in 20/25 Kock patients versus 0/29 other ileal neobladders at mean 13 months, yet four in each group had low serum B12. The proposed 50 cm ileal threshold was an inference from that study, not an absolute safe-versus-unsafe cutoff.[24]

Terai found malabsorption in 3/9 tested Kock patients and 4/6 tested Indiana patients, while no patient in the larger serum-level cohorts had B12 below 200 pg/mL. Neither 33% nor 80% should be presented as a universal rate of clinical B12 deficiency after Kock diversion.[25] In a 20-patient pediatric/adolescent series followed 5–12 years, two developed subnormal B12; renal dysfunction also complicated interpretation of methylmalonic acid.[26]

Normal electrolytes in an early selected series do not establish that acidosis is clinically insignificant over a lifetime. Monitor renal function, bicarbonate/electrolytes and nutritional status. EAU recommends annual B12 after bowel diversion; AUA recommends postcystectomy laboratory assessment every 3–6 months for 2–3 years, then annually. Functional follow-up must continue alongside disease-specific surveillance.[27][4]

Do not routinely screen or treat asymptomatic bacteriuria in a reconstructed urinary tract; use symptoms and established exceptions, including planned mucosa-breaching urological procedures, to guide culture and treatment.[28]

See Vitamin B12 Supplementation, Urinary Acidifiers and Alkalinizers, and Mucus Management.

T-pouch and Other Alternatives​

The T-pouch replaced the intussuscepted afferent nipple with a serosa-lined ileal tunnel. Its first 40-patient report had one perioperative death unrelated to diversion and no late complications at mean 10.5 months; this was not proof of eliminating long-term valve-related morbidity.[29]

The subsequent USC-STAR randomized comparison did not establish superior three-year renal preservation with T-pouch over Studer reconstruction and found more pouch-related reintervention. See T-Pouch Modification for the trial and limitations.[30]

The later fecal T-pouch reports concern continent ileostomy and must not supply urinary continence estimates. The urinary reconstruction choice should instead balance bowel availability, kidney function, outlet requirements, patient preference and the team's experience; selected historical series do not prove that any reservoir universally minimizes stones, revisions and B12 deficiency.

See Also​

References​

1. Skinner DG, Boyd SD, Lieskovsky G. "Clinical Experience With the Kock Continent Ileal Reservoir for Urinary Diversion." J Urol. 1984;132(6):1101–7. doi:10.1016/s0022-5347(17)50052-x

2. Elmajian DA, Stein JP, Esrig D, et al. "The Kock Ileal Neobladder: Updated Experience in 295 Male Patients." J Urol. 1996;156(3):920–5. doi:10.1016/s0022-5347(01)65663-5

3. Ghoneim MA, Kock NG, Lycke G, el-Din AB. "An Appliance-Free, Sphincter-Controlled Bladder Substitute: The Urethral Kock Pouch." J Urol. 1987;138(5):1150–4. doi:10.1016/s0022-5347(17)43531-2

4. American Urological Association / ASCO / ASTRO / SUO. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer. 2024 amendment. Statements 13–14 and 31–32 and discussions. Guideline.

5. Skinner DG, Lieskovsky G, Boyd SD. "Continent Urinary Diversion. A 5 1/2 Year Experience." Ann Surg. 1988;208(3):337–44. doi:10.1097/00000658-198809000-00011

6. Arai Y, Okada Y, Matsuda T, et al. "Afferent Nipple Valve Malfunction Caused by Anchoring Collar: An Unexpected Late Complication of the Kock Continent Ileal Reservoir." J Urol. 1991;145(1):29–32. doi:10.1016/s0022-5347(17)38238-1

7. Skinner DG, Lieskovsky G, Boyd SD. "Continuing Experience With the Continent Ileal Reservoir (Kock Pouch) as an Alternative to Cutaneous Urinary Diversion: An Update After 250 Cases." J Urol. 1987;137(6):1140–5. doi:10.1016/s0022-5347(17)44429-6

8. Chen KK, Chang LS, Chen MT, et al. "Clinical Experience of Kock Pouch Continent Urinary Diversion." Urology. 1990;35(4):317–20. doi:10.1016/0090-4295(90)80154-f

9. Henriet MP, Neyra P, Elman B. "Kock Pouch Procedures: Continuing Experience and Evolution in 135 Cases." J Urol. 1991;146(1):16–20. doi:10.1016/s0022-5347(17)37703-0

10. Arai Y, Kawakita M, Terachi T, et al. "Long-Term Followup of the Kock and Indiana Pouch Procedures." J Urol. 1993;150(1):51–5. doi:10.1016/s0022-5347(17)35394-6

11. Okada Y, Shichiri Y, Terai A, et al. "Management of Late Complications of Continent Urinary Diversion Using the Kock Pouch and the Indiana Pouch Procedures." Int J Urol. 1996;3(5):334–9. doi:10.1111/j.1442-2042.1996.tb00549.x

12. Kock NG, Ghoneim MA, Lycke KG, Mahran MR. "Replacement of the Bladder by the Urethral Kock Pouch: Functional Results, Urodynamics and Radiological Features." J Urol. 1989;141(5):1111–6. doi:10.1016/s0022-5347(17)41185-2

13. Ghoneim MA, Shaaban AA, Mahran MR, Kock NG. "Further Experience With the Urethral Kock Pouch." J Urol. 1992;147(2):361–5. doi:10.1016/s0022-5347(17)37238-5

14. Steven K, Poulsen AL. The orthotopic Kock ileal neobladder: functional results, urodynamic features, complications and survival in 166 men. J Urol. 2000;164(2):288–295. PMID:10893568.

15. Chen KK, Chang LS, Chen MT. "Urodynamic and Clinical Outcome of Kock Pouch Continent Urinary Diversion." J Urol. 1989;141(1):94–7. doi:10.1016/s0022-5347(17)40602-1

16. Gotoh M, Yoshikawa Y, Sahashi M, et al. Urodynamic study of storage and evacuation of urine in patients with a urethral Kock pouch. J Urol. 1995;154(5):1850–1853. PMID:7563361.

17. Stein JP, Freeman JA, Esrig D, et al. Complications of the afferent antireflux valve mechanism in the Kock ileal reservoir. J Urol. 1996;155(5):1579–1584. PMID:8627827.

18. Stein JP, Huffman JL, Freeman JA, et al. "Stenosis of the Afferent Antireflux Valve in the Kock Pouch Continent Urinary Diversion: Diagnosis and Management." J Urol. 1994;151(2):338–40. doi:10.1016/s0022-5347(17)34942-x

19. Locke JA, Neu S, Herschorn S. "Diagnosis and Management of Kock Afferent Nipple Valve Obstruction." Urology. 2021;152:173–7. doi:10.1016/j.urology.2021.02.023

20. Carr LK, Webster GD. "Kock Versus Right Colon Continent Urinary Diversion: Comparison of Outcome and Reoperation Rate." Urology. 1996;48(5):711–4. doi:10.1016/S0090-4295(96)00424-4

21. Ginsberg D, Huffman JL, Lieskovsky G, Boyd S, Skinner DG. "Urinary Tract Stones: A Complication of the Kock Pouch Continent Urinary Diversion." J Urol. 1991;145(5):956–9. doi:10.1016/s0022-5347(17)38499-9

22. Terai A, Ueda T, Kakehi Y, et al. Urinary calculi as a late complication of the Indiana continent urinary diversion: comparison with the Kock pouch procedure. J Urol. 1996;155(1):66–68. PMID:7490900.

23. European Association of Urology. EAU Guidelines on Urolithiasis. 2026. Bladder stones in urinary diversion, sections 6.4.5 and 6.6. Guideline.

24. Pannek J, Haupt G, Schulze H, Senge T. Influence of continent ileal urinary diversion on vitamin B12 absorption. J Urol. 1996;155(4):1206–1208. PMID:8632531.

25. Terai A, Okada Y, Shichiri Y, et al. "Vitamin B12 Deficiency in Patients With Urinary Intestinal Diversion." Int J Urol. 1997;4(1):21–5. doi:10.1111/j.1442-2042.1997.tb00133.x

26. Abd-el-Gawa G, Abrahamsson K, Norlén L, Hjälmås K, Hanson E. "Vitamin B12 and Folate After 5–12 Years of Continent Ileal Urostomy (Kock Reservoir) in Children and Adolescents." Eur Urol. 2002;41(2):199–205. doi:10.1016/s0302-2838(01)00032-x

27. European Association of Urology. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. 2026. Functional follow-up, section 7.4. Guideline.

28. European Association of Urology. EAU Guidelines on Urological Infections. 2026. Reconstructed lower urinary tracts and asymptomatic bacteriuria, sections 3.3.5.d.5 and 3.3.7. Guideline.

29. Stein JP, Lieskovsky G, Ginsberg DA, Bochner BH, Skinner DG. "The T Pouch: An Orthotopic Ileal Neobladder Incorporating a Serosal Lined Ileal Antireflux Technique." J Urol. 1998;159(6):1836–42. doi:10.1016/S0022-5347(01)63170-7

30. Skinner EC, Fairey AS, Groshen S, et al. Randomized trial of Studer pouch versus T-pouch orthotopic ileal neobladder in patients with bladder cancer. J Urol. 2015;194(2):433–439. doi:10.1016/j.juro.2015.03.101.